Palm Beach Atlantic University is a comprehensive interdenominational faith-based university with a core emphasis on character formation by integrating a Christian worldview with the liberal arts and selected professional studies. It is located in West Palm Beach, in the U.S. state of Florida approximately one mile from the Atlantic Ocean on the Intracoastal Waterway. Its purpose is to offer a curriculum of rigorous studies and a program of student activities dedicated to the development of lifetime learning, leadership and service to mankind. The mean SAT is 1270. The student to faculty ratio is 13:1 with 162 faculty. William “Bill” M. B. Fleming, Jr. serves as president of the university. Wikipedia.
News Article | February 16, 2017
The Community for Accredited Online Schools, a leading resource provider for higher education information, has ranked the best schools with online programs in the state of Florida for 2017. A total of 45 schools received honors for their online education offerings, with University of Florida, University of Miami, Florida State University, University of South Florida-Main Campus, Jacksonville University, Tallahassee Community College and Florida Keys Community College earning top spots overall. More than a dozen unique data points were evaluated to determine each school’s score. “The schools on our Best Online Schools list for Florida all meet high standards of excellence for students who want to succeed outside of a brick-and-mortar classroom,” said Doug Jones, CEO and founder of AccreditedSchoolsOnline.org. Colleges and universities on the Best Online Schools list must meet specific base requirements to be included. Qualifications include being institutionally accredited and holding public or private not-for-profit status. Each college was also scored based on additional criteria that includes the student/teacher ratio, graduation rate, employment services and financial aid availability. For more details on where each school falls in the rankings and the data and methodology used to determine the lists, visit: Florida’s Best Online Schools for 2017 include the following: Adventist University of Health Sciences Ave Maria University Barry University Bethune-Cookman University Broward College City College-Fort Lauderdale Daytona State College Embry-Riddle Aeronautical University-Worldwide Everglades University Florida Agricultural and Mechanical University Florida Atlantic University Florida Gulf Coast University Florida Institute of Technology Florida International University Florida Keys Community College Florida SouthWestern State College Florida State College at Jacksonville Florida State University Hobe Sound Bible College Hodges University Indian River State College Jacksonville University Johnson & Wales University-North Miami Keiser University-Ft. Lauderdale Lynn University Nova Southeastern University Palm Beach Atlantic University Saint Leo University South Florida Bible College and Theological Seminary Southeastern University St. Petersburg College St. Thomas University State College of Florida-Manatee-Sarasota Stetson University Tallahassee Community College The Baptist College of Florida The University of West Florida Trinity College of Florida University of Central Florida University of Florida University of Miami University of North Florida University of South Florida-Main Campus Warner University Webber International University ### About Us: AccreditedSchoolsOnline.org was founded in 2011 to provide students and parents with quality data and information about pursuing an affordable, quality education that has been certified by an accrediting agency. Our community resource materials and tools span topics such as college accreditation, financial aid, opportunities available to veterans, people with disabilities, as well as online learning resources. We feature higher education institutions that have developed online learning programs that include highly trained faculty, new technology and resources, and online support services to help students achieve educational success.
News Article | February 22, 2017
The Global Wellness Summit (GWS), the world’s preeminent gathering of decision makers in the wellness industry, today officially announced The Breakers Palm Beach as this year’s host sponsor, a first for a hotel property, which will have a key role in shaping the content of the 11th annual conference, to take place in Palm Beach, Florida, October 9-11, 2017. The Breakers is supported in their GWS sponsorship efforts by two Florida-based institutions, Palm Beach Atlantic University and Cigna Corporation. “Bringing the Summit back to the U.S., whose last gathering took place in collaboration with the Aspen Institute in Colorado, opens up great opportunities for a dynamic agenda that includes visionaries and entrepreneurs that make up one of the largest and most innovative wellness markets in the world. And easy international access to Palm Beach, as well as The Breakers’ inherent beauty and coveted beachfront location, will undoubtedly be a draw for our global delegation,” said Susie Ellis, GWS chairman and CEO. “However, we anticipate that the biggest impact The Breakers will have on attendees is understanding their unwavering commitment to the well-being of their team, community and environment, and how that ultimately drives guest satisfaction.” GWS delegates, key influencers from the $3.72 trillion global wellness industry, will be given the unique opportunity to experience some of The Breakers initiatives first hand. Attendees will learn of the resort’s longstanding, committed owners and executive team, who have developed a wellness-focused business that empowers team members to attain professional and personal goals and reach their greatest potential. The result is an engaging, collaborative and high-achieving workforce, to which CEO Paul Leone attributes the resort’s success as one of America’s leading and most profitable independent hotels. Thanks to Leone’s leadership (since 1994) and the owners’ relentless dedication and unrivaled investment of over $30 million each year in capital improvements, The Breakers stays on a path of continuous renewal to thrive in the highly competitive hospitality market. “We believe that the heart and soul of an organization drives its long-term success – a belief that was instilled in our culture over 120 years ago by our founder, Henry Morrison Flagler,” said Leone. “We look forward to not only sharing our many initiatives - including our dedicated Wellness Team, unique wellness incentives, healthcare discounts, and financial wellness programs that include college and retirement planning – with Global Wellness Summit delegates, but anticipate engaging them directly in our spirit of community service and environmental advocacy.” Leone also thanked The Breakers’ co-sponsors Palm Beach Atlantic University, a comprehensive, interdenominational Christian university, and Cigna Corporation, a global health service company dedicated to helping people improve their well-being. Community and civic responsibility is a core tenet of The Breakers, and in 2016 alone, its team volunteered 20,670 hours to build homes for the homeless, provided support to enhance the welfare of individuals and families with start-up resources and advocacy, and raised awareness and funds to eradicate illnesses. The resort’s sustainability initiatives include innovative water conservation practices, energy efficiency programs and highly impactful waste reduction measures designed to reduce landfill. “Hotels and resorts, especially those with spa and wellness offerings, need to make the wellness of people and planet a priority. At The Breakers you can really see and feel that this is taking place and is part of their organizational DNA. It’s a great model,” said Ellis. This year’s Summit is co-chaired by Professor Gerry Bodeker, PhD, clinical psychologist and public health academic (University of Oxford, UK; Columbia University, New York); Clare Martorana, formerly of Everyday Health and WebMD, now Digital Service Expert, United States Digital Service; and Maggie Hsu, advisor for U.S. online platform Zappos. The Global Wellness Summit attracts leaders from every sector of the wellness industry: hospitality, tourism, spa, beauty, fitness, nutrition, finance, education, environment, medicine, architecture, workplace wellness, wellness communities and technology. The Summit is an invitation-only gathering for senior executives; for information about attending click here. For sponsorship, contact Michelle Gamble. About the Global Wellness Summit: The Global Wellness Summit (GWS) is an invitation-only international gathering that brings together leaders and visionaries to positively shape the future of the $3.7 trillion global wellness economy. Held in a different location each year, Summits have taken place in the U.S., Switzerland, Turkey, Bali, India, Morocco, Mexico and Austria. The next will be held at The Breakers, Palm Beach, Florida from Oct. 9-11, 2017. The Breakers Palm Beach is an iconic, luxury oceanfront resort, renowned as a destination of world-class hospitality and service, and seaside glamour. Situated on 140 acres in the heart of Palm Beach, Florida, the hotel features 538 guest rooms and suites, which includes the private-access Flagler Club, an ultra-luxury boutique hotel nestled atop the resort. Its multi-faceted amenities and services include nine distinctive restaurants; two championship golf courses and a golf academy; a new luxury spa; a Mediterranean-style beach club with poolside bungalows for daytime rental, four oceanfront pools and watersports, tennis, a Family Entertainment Center and an extensive program of family and children’s activities; and 11 on-site boutiques. The Breakers also features 70,000-square feet of meeting and event space and services, including an oceanfront conference center, ballrooms, executive meeting rooms and outdoor venues. Thanks to the dedication of its longstanding family ownership the resort continues to thrive independent of chain affiliation, re-investing over $30 million each year in capital improvements and revitalization.
Lin S.,Le Moyne College |
Zimmer J.C.,Le Moyne College |
Lee V.,Palm Beach Atlantic University
Computers and Education | Year: 2013
Combining the Web and mobile technology, podcasting can be an effective tool for mobile and electronic learning, as it provides a learning environment anytime and anywhere. This research investigated how the Unified Theory of Acceptance and Use of Technology (UTAUT) (Venkatesh, Thong, & Xu, 2012) can be applied to study the adoption of podcasting in higher education. Specifically, it examined whether and how user type (teachers or students) may affect differently adoption patterns of podcasting for educational purposes. The key findings include that for intent to adopt podcasting, effort expectancy is more important to students than teachers, while facilitating conditions factors such as copyright clearance and technical support availability are more important to teachers than students. The overall results are expected to contribute to theoretical development and industrial practices in promoting the acceptance of podcasting for educational purposes. © 2013 Elsevier Ltd. All rights reserved.
Kyle J.A.,Samford University |
Brown D.A.,Palm Beach Atlantic University |
Hill J.K.,Samford University
Annals of Pharmacotherapy | Year: 2013
Objective: To review the pharmacology, pharmacokinetics, safety, and efficacy of avanafil and evaluate relevant clinical trial data. Data Sources: A MEDLINE, International Pharmaceutical Abstracts, ClinicalTrials.gov, and Google Scholar searches (1966 to July 2013) were conducted using the key words: avanafil, erectile dysfunction, and phosphodiesterase type 5 (PDE5) inhibitor. Study Selection and Data Extraction: Articles evaluating avanafil for erectile dysfunction (ED) published in English and using human subjects were selected. Five clinical trials were identified. References cited in identified articles were used for additional citations. Data Synthesis: Avanafil is a highly selective PDE5 inhibitor that is a competitive antagonist of cyclic guanosine monophosphate. Specifically, avanafil has a high ratio of inhibiting PDE5 as compared with other PDE subtypes allowing for the drug to be used for ED while minimizing adverse effects. Absorption occurs quickly following oral administration with a median Tmax of 30 to 45 minutes and a terminal elimination half-life of 5 hours. Additionally, it is predominantly metabolized by cytochrome P450 3A4. As such, avanafil should not be co-administered with strong cytochrome P450 3A4 inhibitors. Dosage adjustments are not warranted based on renal function, hepatic function, age or gender. Five clinical trials suggest that avanafil 100 and 200 mg doses are effective in improving the Sexual Encounter Profile and the Erectile Function Domain scores among men as part of the International Index of Erectile Function. A network meta-analysis comparing the PDE5 inhibitors revealed avanafil was less effective on Global Assessment Questionnaire question 1 while safety data indicated no major differences among the different PDE5 inhibitors. The most common adverse effects reported from the clinical trials associated with avanafil were headache, flushing, nasal congestion, nasopharyngitis, sinusitis, and dyspepsia. Conclusions: Avanafil is a potent PDE5 inhibitor and is an effective treatment option for ED. © The Author(s) 2013.
Andrassy B.M.,Palm Beach Atlantic University
Journal of Child and Adolescent Psychiatric Nursing | Year: 2016
PROBLEM: Restraints and/or seclusions (R/S) are events that have the potential to cause patient injury, staff injury, re-traumatization, and even death. There is a gap in available data regarding alternative strategies for reducing R/S. METHOD: A 140-bed children and adolescent residential treatment hospital implemented a “Feelings Thermometer Scale” on each unit. The “Feelings Thermometer” allowed the resident to point to a face on the scale to rate how they were feeling from “Cool” to “On Fire!” Once the resident identified with a feeling and rating, options were offered for alternative cool down locations corresponding to each level of escalation. Data were analyzed 6 weeks before and 6 weeks after implementation of the “Feelings Thermometer.”. FINDINGS: There were 129 R/S during the 6-week period prior to the implementation of the “Feelings Thermometer.” There were a total of 91 R/S during the 6-week period postimplementation of the “Feelings Thermometer.” Overall, a 29.1% decrease in R/S was experienced throughout the hospital. CONCLUSION: The findings of this study suggest that further investigation may be warranted to promote alternative R/S reduction strategies. © 2016 Wiley Periodicals, Inc
Henneman A.,Palm Beach Atlantic University |
Thornby K.-A.,Palm Beach Atlantic University
American Journal of Health-System Pharmacy | Year: 2012
Purpose. The literature describing the risk of hypotension in patients receiving concomitant therapy with a calcium-channel blocker (CCB) and a macrolide antibiotic is reviewed. Summary. A literature search was conducted to identify studies and reports describing significant drug interactions between CCBs and macrolide antibiotics resulting in hypotension. One retrospective clinical trial, one pharmacokinetics study, and five case reports were found using MEDLINE. While both dihydropyridine and nondihydropyridine CCBs are cytochrome P-450 isoenzyme 3A4 (CYP3A4) substrates, verapamil was the CCB implicated in three of the five case reports. Based on currently available literature, it is unknown whether the risk of clinically significant hypotension is higher for patients receiving nondihydropyridine CCBs; however, due to the drugs'effects on the coronary arteries, there is the potential for more-serious cardiac complications with these agents. Both erythromycin and clarithromycin have been shown to prolong the Q-T interval, an effect that appears to increase when these drugs are given with CYP3A4 inhibitors. The potential for Q-T interval prolongation by both erythromycin and clarithromycin may increase the risk of clinically relevant hypotension and even shock in patients taking CCBs, in particular nondihydropyridines. Conclusion. Potentially significant hypotension and shock may occur when macrolide antibiotics, particularly erythromycin and clarithromycin, are administered concomitantly with CCBs. The frequency of hypotension as a result of concomitant CCB and macrolide administration appears to be small, but the risk of adverse effects and the severity of the effects appear to be greater for those patients who are older and in those with multiple comorbidities. Copyright © 2012, American Society of Health-System Pharmacists, Inc. All rights reserved.
Brown D.A.,Palm Beach Atlantic University |
Ferrill M.J.,Palm Beach Atlantic University
Annals of Pharmacotherapy | Year: 2012
Pharmacists can be involved in many functions of the medical mission team. Particularly, they can play a large role in formulary development, acquisition of medications, and organization of medications before and during the mission trip. Important factors for consideration in formulary development and logistical planning include the group's budget; importation laws and regulations of the country being visited; transportation and storage of medications and supplies; disease states anticipated; whether controlled substances will be included; whether medical or surgical procedures will be provided; age distribution and languages of the population to be treated; whether sample medications will be used; handling of unused medications and supplies after the trip; and considerations of the population's cultural beliefs. Various organizations are available to provide medications for medical mission efforts at little to no cost, and knowledge of these organizations will help to facilitate the process of medication acquisition. Additionally, pharmacists can provide insight regarding the logistical set-up and workflow considerations during the mission experience.
Haines S.L.,Palm Beach Atlantic University |
Popovich N.G.,University of Illinois at Chicago
American Journal of Pharmaceutical Education | Year: 2014
A small nonprofit private college with limited resources and a high proportion of junior faculty developed a nontraditional external faculty mentor program in the summer of 2011 in response to the American Association of Colleges of Pharmacy (AACP) faculty survey data regarding the professional development needs of pharmacy faculty members. Experienced faculty members with national reputations from other colleges and schools of pharmacy were hired as consultants to serve as mentors for assigned faculty members. Programgoals were to provide directed, individual mentorship for pharmacy practice and basic science faculty members, expand peer review of faculty teaching prowess, and enhance monthly faculty development programming. The latter was based upon the specific needs assessment of the faculty. Program outcomes reported will include faculty satisfaction (AACP faculty survey data) changes over time, achievement of board certification for clinical faculty members and other credentialing, and other benchmarks, eg, publications, grant funding, service engagement (site development, professional organizations), after the implementation of the nontraditional faculty-mentoring program.
Brown D.A.,Palm Beach Atlantic University |
Ferrill M.J.,Palm Beach Atlantic University
Annals of Pharmacotherapy | Year: 2012
With an increasing number of new pharmacy schools/colleges and expansion of existing ones, pharmacy schools/colleges are often in need of elective rotation experiences as part of the final year advanced pharmacy practice experience (APPE) program. Offering a medical missions elective APPE in either a domestic or international setting is a unique opportunity to expose pharmacy students to direct patient care. APPE students can be involved in triaging patients, compounding and dispensing medications, and providing patient education. As part of this APPE, pharmacy students are expected to complete projects such as formulary development, case presentations, book club discussions, journal reflections, manuscript preparations, and trip logistics planning. An elective APPE focused on medical missions facilitates the learning process and promotes the emergence of team leaders and leadership skills in general.
Chahine E.B.,Palm Beach Atlantic University |
Karaoui L.R.,Lebanese American University |
Mansour H.,Lebanese American University
Annals of Pharmacotherapy | Year: 2014
Objective: To review the chemistry, pharmacology, microbiology, pharmacokinetics, pharmacodynamics, clinical efficacy, safety, dosage, and administration of bedaquiline, a novel oral diarylquinoline antimycobacterial agent approved by the Food and Drug Administration for the treatment of adults with pulmonary multidrug-resistant tuberculosis (MDR-TB). Data Sources: A search of PubMed (January 2004-May 2013) and International Pharmaceutical Abstracts (January 2004-May 2013) using the search terms bedaquiline, diarylquinoline, R207910, and TMC207 was performed. Supplementary sources included proceedings of the Union World Conference on Lung Health. Study Selection and Data Extraction: Preclinical data as well as Phase 1 and 2 studies published in English were evaluated. Data Synthesis: Bedaquiline possesses a unique mechanism of action that disrupts the activity of the mycobacterial adenosine triphosphate synthase. Clinical trials have been conducted evaluating the use of bedaquiline in combination with a background regimen for the treatment of adults with pulmonary MDR-TB. Bedaquiline has an excellent in vitro activity against Mycobacterium tuberculosis, including multidrug resistant M tuberculosis; however, its side effect profile limits its use against MDR-TB when no other effective regimen can be provided. Bedaquiline carries Black Box warnings for increased risk of unexplained mortality and QT prolongation. Bedaquiline is metabolized via the CYP3A4 isoenzyme and thus interacts with rifamycins and several antiretrovirals. Conclusions: In an era of emerging resistance and given the suboptimal efficacy and toxicity of currently available regimens for MDR-TB, bedaquiline represents a great addition to the existing armamentarium of anti-TB agents particularly in areas of the world where the disease is endemic. © The Author(s) 2013.